The previous page is sending you to https://www.globenewswire.com/news-release/2023/03/28/2635468/0/en/Allarity-Therapeutics-Provides-Updates-for-IXEMPRA-and-Stenoparib-Phase-2-Monotherapy-Clinical-Studies.html.

 If you do not want to visit that page, you can return to the previous page.